An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses
NCT00377273
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
Actinic Keratoses
Interventions
DRUG:
fluorouracil cream 0.5%
Sponsor
Sanofi